相关实验视频
Updated: Jul 5, 2025
20:16
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
9.3K
与暴露于辐射或其他致癌物质有关的癌症的最小延迟效应
Mark P Little1,2, Markus Eidemüller3, J Christian Kaiser3
1Radiation Epidemiology Branch, National Cancer Institute, Bethesda, MD, 20892-9778, USA. mark.little@nih.gov.
British journal of cancer
|January 11, 2024
概括
一个新的随机模型提供了一个比固定时间更准确的方法来估计癌症风险潜伏期. 这种基于生物学的方法,使用临床数据,更好地反映瘤生长动态,以改善风险评估和查策略.
科学领域:
- 辐射瘤学 辐射瘤学
- 癌症流行病学癌症流行病学
- 生物统计学 生物统计学
背景情况:
- 目前的辐射相关癌症风险估计通常依赖于固定的最小潜伏期.
- 现有的延迟经验模型在准确描述从零持续增长方面存在局限性.
- 随机,基于生物学的方法为建模癌症延迟提供了更合理的方法,可以从临床数据中直接估计.
研究的目的:
- 通过使用临床瘤生长数据来推导一个随机生物基延迟模型的参数.
- 为了比较实证延迟函数与随机模型预测的合适性.
- 探索基于生物学的延迟模型对一般变异原体暴露和癌症查的影响.
主要方法:
- 从各种癌症类型的瘤生长数据中获得模型参数.
- 最小方形将两个实证延迟函数与随机模型预测的累积概率相配合.
主要成果:
- 观察到瘤生长率的显著变化,白血病特别快速生长,前列腺/甲状腺癌生长缓慢.
- 前列腺和甲状腺瘤的缓慢生长率表明临床检测的门很低 (约为106个细胞).
- 这两种实证延迟函数都非常接近随机生物模型对所有研究的瘤类型预测的累积概率.
结论:
- 基于生物的随机模型,通过独立于特定致癌物质的临床数据进行验证,为估计癌症延迟提供了可靠的方法.
- 该模型的适用性扩展到一般的瘤生长,提供了有关各种变异原体的潜伏时间的见解.
- 这些发现可能会为癌症查的策略提供信息,特别是那些使用成像技术的策略.
更多相关视频
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
844
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.3K
相关概念视频
02:59Biological Effects of Radiation
15.5K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.5K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
01:25Mutagenicity and Carcinogenicity
1.3K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K
01:19Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:21Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353